The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma - PubMed

The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma - PubMed

The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma

Raul Caso 1, Francisco Sanchez-Vega 2, Kay See Tan 3, Brooke Mastrogiacomo 4, Jian Zhou 1, Gregory D Jones 1, Bastien Nguyen 5, Nikolaus Schultz 5, James G Connolly 1, Whitney S Brandt 1, Matthew J Bott 6, Gaetano Rocco 6, Daniela Molena 6, James M Isbell 6, Yuan Liu 6, Marty W Mayo 7, Prasad S Adusumilli 6, William D Travis 8, David R Jones 9

Affiliations 

• PMID: 32791233
 
• DOI: 10.1016/j.jtho.2020.08.005

Abstract

Introduction: The purpose of the study is to genomically characterize the biology and related therapeutic opportunities of prognostically important predominant histological subtypes in lung adenocarcinoma (LUAD).

Methods: We identified 604 patients with stage I-III LUAD who underwent complete resection and targeted next-generation sequencing using the MSK-IMPACT platform. Tumors were classified according to predominant histologic subtype and grouped by architectural grade (lepidic [LEP], acinar or papillary [ACI/PAP], and micropapillary or solid [MIP/SOL]). Associations between clinicopathologic factors, genomic features, mutational signatures, and recurrence were examined within subtypes and, when appropriate, quantified using competing-risks regression, with adjustment for pathologic stage and extent of resection.

Results: MIP/SOL tumors had higher tumor mutational burden (p<0.001), fraction of genome altered (p=0.001), copy number amplifications (p=0.021), rate of whole-genome doubling (p=0.008), and number of oncogenic pathways altered (p<0.001), compared with LEP and ACI/PAP tumors. Across all tumors, mutational signatures attributed to APOBEC activity were associated with the highest risk of postresection recurrence: SBS2 (p=0.021) and SBS13 (p=0.005). Three oncogenic pathways (p53, Wnt, Myc) were altered with statistical significance in MIP/SOL tumors. Compared with LEP and ACI/PAP tumors, MIP/SOL tumors had a higher frequency of targetable BRAF-V600E mutations (p=0.046). Among ACI/PAP tumors, alterations in the cell cycle (p<0.001) and PI3K (p=0.002) pathways were associated with recurrence; among MIP/SOL tumors, only PI3K alterations were (p=0.049).

Conclusions: These results provide the first in-depth assessment of tumor genomic profiling of predominant LUAD histologic subtypes, their associations with recurrence, and their correlation with targetable driver alterations in patients with surgically resected LUAD.

Keywords: Histologic subtypes; Lung adenocarcinoma; Next-generation sequencing.

Copyright © 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Similar articles

• Prognostic Significance of Cigarette Smoking in Association with Histologic Subtypes of Resected Lung Adenocarcinoma.

  Yi JH, Choi PJ, Jeong SS, Bang JH, Jeong JH, Cho JH.Korean J Thorac Cardiovasc Surg. 2019 Oct;52(5):342-352. doi: 10.5090/kjtcs.2019.52.5.342. Epub 2019 Oct 5.PMID: 31624712 Free PMC article.
• Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.

  Luo J, Huang Q, Wang R, Han B, Zhang J, Zhao H, Fang W, Luo Q, Yang J, Yang Y, Zhu L, Chen T, Cheng X, Wang Y, Zheng J, Wu H, Xia W, Chen H.J Cancer Res Clin Oncol. 2016 Sep;142(9):2031-40. doi: 10.1007/s00432-016-2192-6. Epub 2016 Jul 5.PMID: 27379889
• Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

  Tsao MS, Marguet S, Le Teuff G, Lantuejoul S, Shepherd FA, Seymour L, Kratzke R, Graziano SL, Popper HH, Rosell R, Douillard JY, Le-Chevalier T, Pignon JP, Soria JC, Brambilla EM.J Clin Oncol. 2015 Oct 20;33(30):3439-46. doi: 10.1200/JCO.2014.58.8335. Epub 2015 Apr 27.PMID: 25918286 Free PMC article.
• International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

  Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D.J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.PMID: 21252716 Free PMC article. Review.
• Is there significance in identification of non-predominant micropapillary or solid components in early-stage lung adenocarcinoma?

  Zhao ZR, To KF, Mok TS, Ng CS.Interact Cardiovasc Thorac Surg. 2017 Jan;24(1):121-125. doi: 10.1093/icvts/ivw283. Epub 2016 Sep 5.PMID: 27600912 Review.